Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects

NCT03149848 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus
HIV Infections

Interventions

DRUG: Cabotegravir
DRUG: Rifabutin

Sponsor

ViiV Healthcare

Collaborators

[object Object]